Funder
Indian Council of Medical Research
Central Institute of Medicinal and Aromatic Plants
Reference42 articles.
1. WHO-(2020) [International agency for research in cancer WHO [https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf] [Source: Globocan].
2. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer;Kim;IJC,2014
3. The clonal and mutational evolution spectrum of primary triple negative breast cancers;Shah;Nature,2012
4. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?;Brenton;J. Clin. Oncol.,2005
5. Identification of human triple negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;J. Clin. Investig.,2011